Your browser doesn't support javascript.
loading
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability.
Guerra, Emanuela; Trerotola, Marco; Relli, Valeria; Lattanzio, Rossano; Tripaldi, Romina; Ceci, Martina; Boujnah, Khouloud; Pantalone, Ludovica; Sacchetti, Andrea; Havas, Kristina M; Simeone, Pasquale; Travali, Nicole; Querzoli, Patrizia; Pedriali, Massimo; Roversi, Pietro; Iezzi, Manuela; Tinari, Nicola; Antolini, Laura; Alberti, Saverio.
Afiliação
  • Guerra E; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Trerotola M; Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Relli V; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Lattanzio R; Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Tripaldi R; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Ceci M; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Boujnah K; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Pantalone L; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Sacchetti A; Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Havas KM; Unit of Medical Genetics, Department of Biomedical Sciences - BIOMORF, University of Messina, Messina, Italy.
  • Simeone P; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Travali N; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Querzoli P; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Pedriali M; Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Roversi P; Unit of Medical Genetics, Department of Biomedical Sciences - BIOMORF, University of Messina, Messina, Italy.
  • Iezzi M; Section of Anatomic Pathology, University of Ferrara, Ferrara, Italy.
  • Tinari N; Department of Pathology, Ferrara Hospital, Ferrara, Italy.
  • Antolini L; Italian National Research Council (CNR), Institute of Agricultural Biology and Biotechnology (IBBA-CNR), Milano, Italy.
  • Alberti S; Leicester Institute of Chemical and Structural Biology and Department of Molecular and Cell Biology, University of Leicester, Leicester, England, United Kingdom.
Mol Cancer Ther ; 22(6): 790-804, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36921314

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imunoconjugados Limite: Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Imunoconjugados Limite: Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália